-- Scott Roberts
MONDAY, Sept. 16 (HealthDay News) -- The UroLift system has been
approved by the U.S. Food and Drug Administration to treat low or
blocked urine flow in men aged 50 and older who have an enlarged
The prostate is a walnut-sized gland that's right below the
bladder in males. When the gland becomes enlarged, as tends to
happen in older men, it can restrict the flow of urine.
The new device, which helps prevent the prostate from pressing
on the urethra, was evaluated in clinical studies involving 274 men
between the ages of 49 and 86. Participants given the device
reported fewer symptoms of enlarged prostate and a better quality
of life, the FDA said.
The most common adverse reactions included pain or burning
during urination, blood in the urine and incomplete emptying of the
The UroLift system is produced by NeoTract Inc., based in
To learn more about enlarged prostate, visit
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.